Advertisement
Screener

Xencor, Inc (XNCR) Other Income and Expense

1.7 / 5 stars · 33/95 Roast Me

Xencor, Inc Other Income and Expense

Xencor, Inc (XNCR) reported Other Income and Expense of $15.15 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-05.

Financial Statements › Income Statement › Other Income

us-gaap:NonoperatingIncomeExpense · last filed 2026-08-05

  • Xencor, Inc nonoperating income (expense) for the quarter ending 2026-06-30 was $15.15M, a 622.41% increase year-over-year.
  • Xencor, Inc nonoperating income (expense) for the quarter ending 2026-03-31 was -$50.77M.
  • Xencor, Inc nonoperating income (expense) for the quarter ending 2025-12-31 was $49.36M.
  • Xencor, Inc nonoperating income (expense) for the quarter ending 2025-09-30 was $41.49M, a 435.04% increase year-over-year.
  • Xencor, Inc nonoperating income (expense) for fiscal 2025 was $87.87M.
  • Xencor, Inc nonoperating income (expense) for fiscal 2024 was -$56.52M, a 544.02% decline from fiscal 2023.
  • Xencor, Inc nonoperating income (expense) for fiscal 2023 was $12.73M, a 54.49% decline from fiscal 2022.
  • Xencor, Inc nonoperating income (expense) for fiscal 2022 was $27.96M, a 28.04% decline from fiscal 2021.
Period endNonoperating Income (Expense) 3 monthNonoperating Income (Expense) 3 month as first filedNonoperating Income (Expense) 6 monthNonoperating Income (Expense) 6 month as first filedNonoperating Income (Expense) 9 monthNonoperating Income (Expense) 9 month as first filedNonoperating Income (Expense) 12 monthNonoperating Income (Expense) 12 month as first filed
2026-06-30$15.15M
10-Q · filed 2026-08-05
-$35.63M
10-Q · filed 2026-08-05
$13.74M
derived: sum of 3 quarters · filed 2026-08-05
$55.23M
derived: sum of 4 quarters · filed 2026-08-05
2026-03-31-$50.77M
10-Q · filed 2026-05-06
-$1.41M
derived: sum of 2 quarters · filed 2026-05-06
$40.08M
derived: sum of 3 quarters · filed 2026-05-06
$42.18M
derived: sum of 4 quarters · filed 2026-08-05
2025-12-31$49.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
$90.85M
derived: sum of 2 quarters · filed 2026-02-25
$92.95M
derived: sum of 3 quarters · filed 2026-08-05
$87.87M
10-K · filed 2026-02-25
2025-09-30$41.49M
10-Q · filed 2025-11-05
$43.59M
derived: sum of 2 quarters · filed 2026-08-05
$38.51M
10-Q · filed 2025-11-05
$7.10M
derived: sum of 4 quarters · filed 2026-08-05
2025-06-30$2.10M
10-Q · filed 2026-08-05
-$2.98M
10-Q · filed 2026-08-05
-$34.39M
derived: sum of 3 quarters · filed 2026-08-05
-$26.64M
derived: sum of 4 quarters · filed 2026-08-05
2025-03-31-$5.08M
10-Q · filed 2026-05-06
-$36.49M
derived: sum of 2 quarters · filed 2026-05-06
-$28.73M
derived: sum of 3 quarters · filed 2026-05-06
-$42.14M
derived: sum of 4 quarters · filed 2026-05-06
2024-12-31-$31.41M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-25
-$23.65M
derived: sum of 2 quarters · filed 2026-02-25
-$37.06M
derived: sum of 3 quarters · filed 2026-02-25
-$56.52M
10-K · filed 2026-02-25
2024-09-30$7.75M
10-Q · filed 2025-11-05
$15.99M
10-Q · filed 2024-11-06
-$5.66M
derived: sum of 2 quarters · filed 2025-11-05
-$25.11M
10-Q · filed 2025-11-05
$158.00K
10-Q · filed 2024-11-06
-$10.41M
derived: sum of 4 quarters · filed 2026-02-25
2024-06-30-$13.41M
10-Q · filed 2025-08-06
-$4.97M
10-Q · filed 2024-08-05
-$32.87M
10-Q · filed 2025-08-06
-$15.83M
10-Q · filed 2024-08-05
-$18.16M
derived: sum of 3 quarters · filed 2026-02-25
-$24.16M
derived: sum of 4 quarters · filed 2026-02-25
2024-03-31-$19.45M
10-Q · filed 2025-05-07
-$10.85M
10-Q · filed 2024-05-09
-$4.75M
derived: sum of 2 quarters · filed 2026-02-25
-$10.75M
derived: sum of 3 quarters · filed 2026-02-25
-$6.71M
derived: sum of 4 quarters · filed 2026-02-25
2023-12-31$14.70M
derived: 10-K 12 month − 10-Q/A 9 month · filed 2026-02-25
$8.70M
derived: sum of 2 quarters · filed 2026-02-25
$12.75M
derived: sum of 3 quarters · filed 2026-02-25
$12.73M
10-K · filed 2026-02-25
$18.20M
10-K · filed 2024-02-29
2023-09-30-$6.00M
10-Q/A · filed 2025-02-24
-$6.00M
10-Q · filed 2023-11-08
-$1.96M
derived: sum of 2 quarters · filed 2025-02-24
-$1.98M
10-Q/A · filed 2025-02-24
-$3.36M
10-Q · filed 2023-11-08
$28.16M
derived: sum of 4 quarters · filed 2025-02-27
2023-06-30$4.04M
10-Q/A · filed 2025-02-24
$4.02M
10-Q/A · filed 2025-02-24
$2.65M
10-Q · filed 2023-08-03
$34.16M
derived: sum of 3 quarters · filed 2025-02-27
$40.84M
derived: sum of 4 quarters · filed 2025-02-27
2023-03-31-$19.00K
10-Q/A · filed 2025-02-24
-$1.40M
10-Q · filed 2023-05-08
$30.12M
derived: sum of 2 quarters · filed 2025-02-27
$36.79M
derived: sum of 3 quarters · filed 2025-02-27
$30.82M
derived: sum of 4 quarters · filed 2025-02-27
2022-12-31$30.14M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-27
$36.81M
derived: sum of 2 quarters · filed 2025-02-27
$30.84M
derived: sum of 3 quarters · filed 2025-02-27
$27.96M
10-K · filed 2025-02-27
2022-09-30$6.68M
10-Q · filed 2023-11-08
$702.00K
derived: sum of 2 quarters · filed 2023-11-08
-$2.17M
10-Q · filed 2023-11-08
-$20.76M
derived: sum of 4 quarters · filed 2025-02-24
2022-06-30-$5.97M
10-Q · filed 2023-08-03
-$8.85M
10-Q · filed 2023-08-03
-$27.44M
derived: sum of 3 quarters · filed 2025-02-24
-$26.33M
derived: sum of 4 quarters · filed 2025-02-24
2022-03-31-$2.87M
10-Q · filed 2023-05-08
-$21.46M
derived: sum of 2 quarters · filed 2025-02-24
-$20.35M
derived: sum of 3 quarters · filed 2025-02-24
$22.81M
derived: sum of 4 quarters · filed 2025-02-24
2021-12-31-$18.59M
derived: 10-K/A 12 month − 10-Q 9 month · filed 2025-02-24
-$17.48M
derived: sum of 2 quarters · filed 2025-02-24
$25.68M
derived: sum of 3 quarters · filed 2025-02-24
$38.86M
10-K/A · filed 2025-02-24
2021-09-30$1.11M
10-Q · filed 2022-11-07
$44.27M
derived: sum of 2 quarters · filed 2022-11-07
$57.45M
10-Q · filed 2022-11-07
$57.46M
derived: sum of 4 quarters · filed 2023-02-27
2021-06-30$43.16M
10-Q · filed 2022-08-03
$56.35M
10-Q · filed 2022-08-03
$56.35M
derived: sum of 3 quarters · filed 2023-02-27
$60.52M
derived: sum of 4 quarters · filed 2023-02-27
2021-03-31$13.19M
10-Q · filed 2022-05-05
$13.19M
derived: sum of 2 quarters · filed 2023-02-27
$17.36M
derived: sum of 3 quarters · filed 2023-02-27
$19.95M
derived: sum of 4 quarters · filed 2023-02-27
2020-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-27
$4.18M
derived: sum of 2 quarters · filed 2023-02-27
$6.76M
derived: sum of 3 quarters · filed 2023-02-27
$7.46M
10-K · filed 2023-02-27
2020-09-30$4.17M
10-Q · filed 2021-11-08
$6.75M
derived: sum of 2 quarters · filed 2021-11-08
$7.46M
10-Q · filed 2021-11-08
$10.83M
derived: sum of 4 quarters · filed 2022-02-24
2020-06-30$2.58M
10-Q · filed 2021-08-04
$3.28M
10-Q · filed 2021-08-04
$6.66M
derived: sum of 3 quarters · filed 2022-02-24
$10.36M
derived: sum of 4 quarters · filed 2022-02-24
2020-03-31$703.00K
10-Q · filed 2021-05-05
$4.08M
derived: sum of 2 quarters · filed 2022-02-24
$7.78M
derived: sum of 3 quarters · filed 2022-02-24
$11.37M
derived: sum of 4 quarters · filed 2022-02-24
2019-12-31$3.37M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-24
$7.08M
derived: sum of 2 quarters · filed 2022-02-24
$10.66M
derived: sum of 3 quarters · filed 2022-02-24
$13.36M
10-K · filed 2022-02-24
2019-09-30$3.70M
10-Q · filed 2020-11-06
$7.29M
derived: sum of 2 quarters · filed 2020-11-06
$9.99M
10-Q · filed 2020-11-06
$12.88M
derived: sum of 4 quarters · filed 2021-02-24
2019-06-30$3.59M
10-Q · filed 2020-08-05
$6.29M
10-Q · filed 2020-08-05
$9.17M
derived: sum of 3 quarters · filed 2021-02-24
$11.67M
derived: sum of 4 quarters · filed 2021-02-24
2019-03-31$2.70M
10-Q · filed 2020-05-08
$5.58M
derived: sum of 2 quarters · filed 2021-02-24
$8.08M
derived: sum of 3 quarters · filed 2021-02-24
$10.51M
derived: sum of 4 quarters · filed 2021-02-24
2018-12-31$2.88M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24
$5.38M
derived: sum of 2 quarters · filed 2021-02-24
$7.80M
derived: sum of 3 quarters · filed 2021-02-24
$8.96M
10-K · filed 2021-02-24
2018-09-30$2.50M
10-Q · filed 2019-11-05
$4.92M
derived: sum of 2 quarters · filed 2019-11-05
$6.08M
10-Q · filed 2019-11-05
$7.03M
derived: sum of 4 quarters · filed 2020-02-25
2018-06-30$2.42M
10-Q · filed 2019-08-07
$3.58M
10-Q · filed 2019-08-07
$4.53M
derived: sum of 3 quarters · filed 2020-02-25
$5.63M
derived: sum of 4 quarters · filed 2020-02-25
2018-03-31$1.16M
10-Q · filed 2019-05-09
$2.11M
derived: sum of 2 quarters · filed 2020-02-25
$3.21M
derived: sum of 3 quarters · filed 2020-02-25
$4.28M
derived: sum of 4 quarters · filed 2020-02-25
2017-12-31$954.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-25
$2.06M
derived: sum of 2 quarters · filed 2020-02-25
$3.12M
derived: sum of 3 quarters · filed 2020-02-25
$4.17M
10-K · filed 2020-02-25
2017-09-30$1.10M
10-Q · filed 2018-11-05
$2.17M
derived: sum of 2 quarters · filed 2018-11-05
$3.22M
10-Q · filed 2018-11-05
$4.02M
derived: sum of 4 quarters · filed 2019-02-26
2017-06-30$1.06M
10-Q · filed 2018-08-07
$2.12M
10-Q · filed 2018-08-07
$2.92M
derived: sum of 3 quarters · filed 2019-02-26
$3.50M
derived: sum of 4 quarters · filed 2019-02-26
2017-03-31$1.05M
10-Q · filed 2018-05-07
$1.86M
derived: sum of 2 quarters · filed 2019-02-26
$2.44M
derived: sum of 3 quarters · filed 2019-02-26
$2.80M
derived: sum of 4 quarters · filed 2019-02-26
2016-12-31$804.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-26
$1.38M
derived: sum of 2 quarters · filed 2019-02-26
$1.74M
derived: sum of 3 quarters · filed 2019-02-26
$2.08M
10-K · filed 2019-02-26
2016-09-30$580.00K
10-Q · filed 2017-11-08
$938.00K
derived: sum of 2 quarters · filed 2017-11-08
$1.27M
10-Q · filed 2017-11-08
$1.59M
derived: sum of 4 quarters · filed 2018-02-28
2016-06-30$358.00K
10-Q · filed 2017-08-07
$693.00K
10-Q · filed 2017-08-07
$1.01M
derived: sum of 3 quarters · filed 2018-02-28
$1.29M
derived: sum of 4 quarters · filed 2018-02-28
2016-03-31$335.00K
10-Q · filed 2017-05-10
$654.00K
derived: sum of 2 quarters · filed 2018-02-28
$929.00K
derived: sum of 3 quarters · filed 2018-02-28
$1.05M
derived: sum of 4 quarters · filed 2018-02-28
2015-12-31$319.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-28
$594.00K
derived: sum of 2 quarters · filed 2018-02-28
$712.00K
derived: sum of 3 quarters · filed 2018-02-28
$746.00K
10-K · filed 2018-02-28
2015-09-30$275.00K
10-Q · filed 2016-11-02
$393.00K
derived: sum of 2 quarters · filed 2016-11-02
$427.00K
10-Q · filed 2016-11-02
$428.00K
derived: sum of 4 quarters · filed 2017-03-01
2015-06-30$118.00K
10-Q · filed 2016-08-03
$152.00K
10-Q · filed 2016-08-03
$153.00K
derived: sum of 3 quarters · filed 2017-03-01
$162.00K
derived: sum of 4 quarters · filed 2017-03-01
2015-03-31$34.00K
10-Q · filed 2016-05-02
$35.00K
derived: sum of 2 quarters · filed 2017-03-01
$44.00K
derived: sum of 3 quarters · filed 2017-03-01
$53.00K
derived: sum of 4 quarters · filed 2017-03-01
2014-12-31$1.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-01
$10.00K
derived: sum of 2 quarters · filed 2017-03-01
$19.00K
derived: sum of 3 quarters · filed 2017-03-01
$35.00K
10-K · filed 2017-03-01
2014-09-30$9.00K
10-Q · filed 2015-11-04
$18.00K
derived: sum of 2 quarters · filed 2015-11-04
$34.00K
10-Q · filed 2015-11-04
$41.00K
derived: sum of 4 quarters · filed 2016-03-08
2014-06-30$9.00K
10-Q · filed 2015-08-05
$25.00K
10-Q · filed 2015-08-05
$32.00K
derived: sum of 3 quarters · filed 2016-03-08
$40.00K
derived: sum of 4 quarters · filed 2016-03-08
2014-03-31$16.00K
10-Q · filed 2015-05-05
$23.00K
derived: sum of 2 quarters · filed 2016-03-08
$31.00K
derived: sum of 3 quarters · filed 2016-03-08
-$49.07M
derived: sum of 4 quarters · filed 2016-03-08
2013-12-31$7.00K
derived: 10-K 12 month − 10-Q 9 month · filed 2016-03-08
$15.00K
derived: sum of 2 quarters · filed 2016-03-08
-$49.09M
derived: sum of 3 quarters · filed 2016-03-08
-$49.74M
10-K · filed 2016-03-08
2013-09-30$8.00K
10-Q · filed 2014-11-10
-$49.09M
derived: sum of 2 quarters · filed 2014-11-10
-$49.75M
10-Q · filed 2014-11-10
2013-06-30-$49.10M
10-Q · filed 2014-08-01
-$49.75M
10-Q · filed 2014-08-01
2013-03-31-$651.00K
10-Q · filed 2014-05-15
2012-12-31-$2.36M
10-K · filed 2015-02-23

Similar stocks

Stock NameCountryMarket CapPE Ratio
Septerna, Inc. (SEPN)United States$1.783B-63.01
ANI PHARMACEUTICALS INC (ANIP)United States$1.810B18.77
COMPASS Pathways plc (CMPS)$1.812B-4.87
Eton Pharmaceuticals, Inc. (ETON)United States$1.701B80.74
Zymeworks Inc. (ZYME)United States$1.902B-12.44
Xeris Biopharma Holdings, Inc. (XERS)United States$1.632B-80.10
Stoke Therapeutics, Inc. (STOK)United States$1.630B-9.82
Rapport Therapeutics, Inc. (RAPP)United States$1.623B-14.56
Sarepta Therapeutics, Inc. (SRPT)United States$1.941B-13.89
Syndax Pharmaceuticals Inc (SNDX)United States$1.606B-8.82